S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Rosen Law Firm Launches Investigation Into Beneficient Securities

Investors holding Beneficient (NASDAQ: BENF) shares face a potential class action lawsuit as Rosen Law Firm investigates allegations that the company disseminated materially misleading business information. The firm is currently seeking individuals who purchased securities to participate in a prospective recovery of losses through a contingency fee arrangement.

Rosen Law Firm Launches Investigation Into Beneficient Securities
Photo: Bio & News

The investigation focuses on whether Beneficient provided an inaccurate picture of its financial health to the public, potentially damaging shareholder value. Rosen Law Firm, which specializes in global securities litigation, is organizing the action for those who suffered financial harm. Investors interested in joining the case or seeking further information can contact Phillip Kim at 866-767-3653 or visit the firm’s dedicated case page.

Rosen Law Firm maintains a history of high-profile securities litigation, including a record-setting settlement against a Chinese company and consistent top-tier rankings from ISS Securities Class Action Services. Founding partner Laurence Rosen, recognized as a Titan of the Plaintiffs' Bar by Law360, leads the firm's practice. While the firm encourages investors to select experienced counsel, it notes that prior legal victories do not guarantee similar outcomes in this specific investigation.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!